Sudarshan Pharma

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE00TV01023
  • NSEID:
  • BSEID: 543828
INR
26.60
-0.04 (-0.15%)
BSENSE

Dec 05

BSE+NSE Vol: 28000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
Share Capital
24.07
24.07
24.07
9.75
9.55
Share Warrants & Outstandings
Total Reserve
103.59
87.64
76.91
20.03
12.96
Shareholder's Funds
131.48
111.71
100.97
29.78
22.51
Minority Interest
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
10.46
10.49
12.79
4.94
5.32
Secured Loans
9.91
9.06
11.78
4.08
2.82
Unsecured Loans
0.55
1.43
1.01
0.86
2.50
Deferred Tax Assets / Liabilities
0.29
0.02
0.18
0.14
0.14
Other Long Term Liabilities
0.49
0.42
0.06
0.04
0.03
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
11.23
10.93
13.03
5.12
5.48
Current Liabilities
Trade Payables
91.83
56.72
91.89
73.75
44.22
Other Current Liabilities
7.59
9.43
5.27
3.22
5.62
Short Term Borrowings
160.27
94.35
21.32
25.65
21.38
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
259.69
160.49
118.48
102.62
71.22
Total Liabilities
402.41
283.13
232.48
137.52
99.26
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
Gross Block
29.05
29.33
22.45
8.49
7.64
Less: Accumulated Depreciation
5.18
3.83
2.56
2.03
1.42
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
Net Block
23.87
25.50
19.89
6.47
6.21
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
6.04
1.88
0.01
0.54
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
Non Current Investments
28.84
12.34
12.34
0.00
0.00
Long Term Loans & Advances
4.56
1.83
1.62
0.94
5.40
Other Non Current Assets
4.25
4.35
0.00
0.00
0.00
Total Non-Current Assets
67.56
45.91
33.86
7.94
11.62
Current Assets Loans & Advances
Current Investments
1.50
1.50
0.00
0.00
0.00
Inventories
140.48
85.74
74.57
46.87
23.96
Sundry Debtors
160.16
122.55
81.51
73.48
60.39
Cash and Bank
0.55
0.14
11.72
0.24
1.25
Other Current Assets
19.26
27.27
19.94
8.97
2.01
Short Term Loans and Advances
12.90
0.02
10.88
0.03
0.02
Total Current Assets
334.85
237.22
198.62
129.58
87.64
Net Current Assets (Including Current Investments)
75.15
76.73
80.14
26.96
16.42
Total Current Assets Excluding Current Investments
333.35
235.72
198.62
129.58
87.64
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
Total Assets
402.41
283.13
232.48
137.52
99.26
Contingent Liabilities
28.58
0.40
0.20
0.19
0.02
Total Debt
170.73
104.84
34.10
30.59
28.23
Book Value per share (adjusted)
5.3
4.642
41.96
30.54
15.72
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 62.85% vs 207.45% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 16.67% vs 600.00% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 9.24% vs 37.59% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 133.71% vs 0.00% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 41.16% vs 19.43% in Mar 2024

Compare Balance Sheet Results of Sudarshan Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
24.07
24.94
-0.87
-3.49%
Share Warrants & Outstandings
Total Reserve
103.59
202.64
-99.05
-48.88%
Shareholder's Funds
131.48
227.58
-96.10
-42.23%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
10.46
39.48
-29.02
-73.51%
Secured Loans
9.91
29.31
-19.40
-66.19%
Unsecured Loans
0.55
10.17
-9.62
-94.59%
Deferred Tax Assets / Liabilities
0.29
-8.29
8.58
103.50%
Other Long Term Liabilities
0.49
0.50
-0.01
-2.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
3.06
-3.06
-100.00%
Total Non-Current Liabilities
11.23
34.76
-23.53
-67.69%
Current Liabilities
Trade Payables
91.83
61.28
30.55
49.85%
Other Current Liabilities
7.59
40.66
-33.07
-81.33%
Short Term Borrowings
160.27
7.56
152.71
2,019.97%
Short Term Provisions
0.00
0.07
-0.07
-100.00%
Total Current Liabilities
259.69
109.57
150.12
137.01%
Total Liabilities
402.41
371.92
30.49
8.20%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
29.05
321.01
-291.96
-90.95%
Less: Accumulated Depreciation
5.18
86.91
-81.73
-94.04%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
23.87
234.09
-210.22
-89.80%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
6.04
0.08
5.96
7,450.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
28.84
0.37
28.47
7,694.59%
Long Term Loans & Advances
4.56
0.00
4.56
0.00%
Other Non Current Assets
4.25
2.26
1.99
88.05%
Total Non-Current Assets
67.56
236.84
-169.28
-71.47%
Current Assets Loans & Advances
Current Investments
1.50
0.00
1.50
0.00%
Inventories
140.48
42.59
97.89
229.84%
Sundry Debtors
160.16
74.19
85.97
115.88%
Cash and Bank
0.55
6.04
-5.49
-90.89%
Other Current Assets
19.26
6.98
12.28
175.93%
Short Term Loans and Advances
12.90
5.29
7.61
143.86%
Total Current Assets
334.85
135.08
199.77
147.89%
Net Current Assets (Including Current Investments)
75.15
25.51
49.64
194.59%
Total Current Assets Excluding Current Investments
333.35
135.08
198.27
146.78%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
402.41
371.92
30.49
8.20%
Contingent Liabilities
28.58
18.51
10.07
54.40%
Total Debt
170.73
47.04
123.69
262.95%
Book Value per share (adjusted)
5.30
91.25
-85.95
-94.19%
Annual - Borrowings
Borrowings 170.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 62.85% vs 207.45% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.49 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.67% vs 600.00% in Mar 2024

Annual - Fixed Assets
Fixed Assets 29.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.24% vs 37.59% in Mar 2024

Annual - Investments
Investments 28.84 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 133.71% vs 0.00% in Mar 2024

Annual - Current Assets
Current Assets 334.85 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 41.16% vs 19.43% in Mar 2024